New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor Symposium.

ABSTRACT: The androgen receptor (AR) is a crucial player in various aspects of male reproduction and has been associated with the development and progression of prostate cancer (PCa). Therefore, the protein is the linchpin of current PCa therapies. Despite great research efforts, the AR signaling pathway has still not been deciphered, and the emergence of resistance is still the biggest problem in PCa treatment. To discuss the latest developments in AR research, the "1st International Androgen Receptor Symposium" offered a forum for the exchange of clinical and scientific innovations around the role of the AR in prostate cancer (PCa) and to stimulate new collaborative interactions among leading scientists from basic, translational, and clinical research. The symposium included three sessions coverin

SUBMITTER: Mehralivand S 

PROVIDER: S-EPMC10795409 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature